Replies to post #240556 on Biotech Values

[swampboots]

MRNA: can't see they will provide evidence of relenting (making nice with ABUS) while this larger problem is culminating:

https://www.nature.com/articles/d41586-021-03535-x?utm_source=Nature+Briefing&utm_campaign=98784a2e58-briefing-dy-20211203&utm_medium=email&utm_term=0_c9dfd39373-98784a2e58-44970129

[DewDiligence]

ABUS/Genevant sue MRNA for patent infringement vis-à-vis COVID vaccine’s delivery mechanism:

https://finance.yahoo.com/news/arbutus-biopharma-genevant-sciences-file-110200327.html

Arbutus Biopharma Corporation and Genevant Sciences today filed a lawsuit in the U.S. District Court for the District of Delaware against Moderna, Inc. and a Moderna affiliate seeking damages for infringement of U.S. Patent Nos. 8,058,069, 8,492,359, 8,822,668, 9,364,435, 9,504,651, and 11,141,378 in the manufacture and sale of MRNA-1273, Moderna’s vaccine for COVID-19. The patents relate to nucleic acid-lipid particles and lipid vesicles, as well as compositions and methods for their use. The filed complaint is available on the Arbutus website.

Genevant is a JV of ABUS and ROIV.

My viewpoint in #msg-166969942 still pertains.

[mick]

thank you